Market Research Logo

AngioDynamics Inc (ANGO) - Financial and Strategic SWOT Analysis Review

AngioDynamics Inc (ANGO) - Financial and Strategic SWOT Analysis Review

- SWOT Analysis Review provides you an provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AngioDynamics Inc (AngioDynamics) provides minimally invasive medical, surgical and diagnostic devices. Its product portfolio encompasses peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. Its products find application in interventional radiology, interventional cardiology, and minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. The company sells its products through direct sales force in the US and through a network of distributors outside the US. It has operations in North America, Europe and Asia. AngioDynamics is headquartered in New York, the US.

AngioDynamics Inc Key Recent Developments

Jul 31,2019: AngioDynamics announces appointment of former Johnson & Johnson executive Karen Licitra to its Board of Directors
Jul 10,2019: AngioDynamics reports fiscal 2019 fourth quarter and full-year financial results
Jun 05,2019: Medline completes AngioDynamics' NAMIC portfolio acquisition
Apr 18,2019: Medline to buy AngioDynamics’ NAMIC portfolio for $167.5m
Apr 02,2019: AngioDynamics announces fiscal 2019 third quarter financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
AngioDynamics Inc - Key Facts
AngioDynamics Inc - Key Employees
AngioDynamics Inc - Key Employee Biographies
AngioDynamics Inc - Major Products and Services
AngioDynamics Inc - History
AngioDynamics Inc - Company Statement
AngioDynamics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AngioDynamics Inc - Business Description
Product Category: Oncology/Surgery
Overview
Performance
Product Category: Vascular Access
Overview
Performance
Product Category: Vascular Interventions & Therapies
Overview
Performance
Geographical Segment: International
Performance
Geographical Segment: The US
Performance
R&D Overview
AngioDynamics Inc - Corporate Strategy
AngioDynamics Inc - SWOT Analysis
SWOT Analysis - Overview
AngioDynamics Inc - Strengths
AngioDynamics Inc - Weaknesses
AngioDynamics Inc - Opportunities
AngioDynamics Inc - Threats
AngioDynamics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AngioDynamics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
AngioDynamics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
AngioDynamics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 31, 2019: AngioDynamics announces appointment of former Johnson & Johnson executive Karen Licitra to its Board of Directors
Jul 10, 2019: AngioDynamics reports fiscal 2019 fourth quarter and full-year financial results
Jun 05, 2019: Medline completes AngioDynamics' NAMIC portfolio acquisition
Apr 18, 2019: Medline to buy AngioDynamics’ NAMIC portfolio for $167.5m
Apr 02, 2019: AngioDynamics announces fiscal 2019 third quarter financial results
Mar 08, 2019: AngioDynamics Wins Patent Infringement Dispute With Bard
Jan 04, 2019: AngioDynamics reports fiscal 2019 second quarter financial results
Sep 27, 2018: AngioDynamics reports fiscal 2019 first quarter financial results
Sep 17, 2018: AngioDynamics to buy patient dose monitoring firm RadiaDyne
Aug 17, 2018: AngioDynamics acquires BioSentry system from Surgical Specialties
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
AngioDynamics Inc, Key Facts
AngioDynamics Inc, Key Employees
AngioDynamics Inc, Key Employee Biographies
AngioDynamics Inc, Major Products and Services
AngioDynamics Inc, History
AngioDynamics Inc, Other Locations
AngioDynamics Inc, Subsidiaries
AngioDynamics Inc, Key Competitors
AngioDynamics Inc, Ratios based on current share price
AngioDynamics Inc, Annual Ratios
AngioDynamics Inc, Annual Ratios (Cont...1)
AngioDynamics Inc, Annual Ratios (Cont...2)
AngioDynamics Inc, Interim Ratios
AngioDynamics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
AngioDynamics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
AngioDynamics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
AngioDynamics Inc, Performance Chart (2015 - 2019)
AngioDynamics Inc, Ratio Charts
AngioDynamics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
AngioDynamics Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report